Chronic BAK exposure is associated with an increase in tear osmolarity

Dr. Eldridge began an interesting thread this past week regarding ocular surface disease in glaucoma patients. He reminded us that dry eye disease can often be silent in patients after chronic administration of BAK preservatives have reduced corneal … [Read more...]

Chronic administration of BAK appears to alter corneal sensitivity

Ocular Surface Disease can be a major problem for glaucoma patients and could result in cell damage, discomfort, loss of quality of vision as well as Quality of Life issues.  Patients may not be able to give reliable feedback regarding dry eye disease.  In the Dec 2011 Journal of French Ophthalmology, Van Went et al evaluated … [Read more...]

Recent study shows preservative-free tafluprost offers effective treatment with less ocular surface impact for glaucoma patients

We have known for years BAK is often a cause for ocular discomfort for patients. "Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma" in Clinical Ophthalmology Jan 2012 looks at tear osmolarity, corneal staining and OSDI in … [Read more...]

Link Between Ocular Surface Disease and Quality of Life in Glaucoma Patients

A link between Quality of Life scores in patients treated for Dry Eye Disease and Glaucoma is documented in the Jan. 2012 American Journal of Ophthalmology publication.  As clinicians we need to be aware of the decrease in QOL with increasing Glaucoma severity by monitoring the ocular surface carefully. Link Between Ocular … [Read more...]

Dry Eyes and Glaucoma, Double Trouble

ruth-d-williams_100

Interesting article by Dr. Ruth Williams from the GLAUCOMA RESEARCH FOUNDATION. Dry Eye Syndrome and glaucoma commonly occur together. Patients may have irksome symptoms, but not associate them with dry eye syndrome. The symptoms of dry eye disease vary from person to person. Symptoms may come and go, and they're often … [Read more...]

Effects of osmoprotection on symptoms, ocular surface damage, and tear film modifications caused by glaucoma therapy

Monaco G, Cacioppo V, Consonni D, Troiano P. Ophthalmology Unit, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan - Italy. Abstract Purpose. To determine the effects of 2 artificial tear formulas on the ocular surface in patients with glaucoma using topical preserved beta-blockers (BB) or … [Read more...]